Health
Clinical efficacy and safety of neratinib for breast cancer | DDDT – Dove Medical Press
Clinical efficacy & safety of neratinib for the treatment of adult patients with advanced or metastatic HER2 positive breast…
Introduction
Breast cancer is the most common malignancy in women (approximately 30% of total), where it represents the first cause of cancer-related death.1
From a biological point of view, breast cancer can be classified into molecularly defined subtypes,…
Continue Reading
-
Noosa News21 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Noosa News24 hours agoNo conviction recorded for teen behind attack on Peter Dutton’s office
-
Business22 hours agoASX 200 lifts on the RBA’s latest interest rate call
-
Noosa News24 hours ago‘They’re not taking the concerns of women seriously’